SCHEMBL28356121

SCHEMBL28356121

O=C(O)N1CCN2CCNCC2C1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.43
HRH3 Q9Y5N1 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
CHRNB3 Q05901 1/20 0.32
CHRNA6 Q15825 1/20 0.32
ARG1 P05089 1/20 0.31
ARG2 P78540 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
POLB P06746 1/20 0.30
HSD17B10 Q99714 1/20 0.30
L3MBTL3 Q96JM7 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22608794 0.86 HTR6 (0.39) HTR6CHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL21039950 0.84 CHRNB2 (0.43) HTR6HRH3CHRNB2CHRNA3CHRNA4
SCHEMBL13462187 0.84 CHRNB2 (0.43) HTR6HRH3CHRNB2CHRNA3CHRNA4
SCHEMBL23301799 0.84 HTR6 (0.50) HTR6HRH3KDM4EALDH1A1CHRNB2
SCHEMBL22608793 0.84 L3MBTL3 (0.33) KDM4EALDH1A1L3MBTL3L3MBTL1
SCHEMBL4541398 0.81 CHRNB2 (0.41) HTR6HRH3CHRNB2CHRNA3CHRNA4
SCHEMBL6903463 0.80 HTR6 (0.39) HTR6HRH3HSD17B10
SCHEMBL21070056 0.80 L3MBTL3 (0.41) HTR6CHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL3157280 0.80 HTR6 (0.44) HTR6HRH3KDM4EALDH1A1ARG1
SCHEMBL23788123 0.80 L3MBTL3 (0.41) HTR6CHRNB2CHRNA3CHRNA4CHRNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409556-A1 BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. 2024-12-12 US disclosed
CN-115835911-A Imidazo [1,2-a ] pyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2023-03-21 CN disclosed
CN-110691784-A Compounds that inhibit MCL-1 protein 美国安进公司 2020-01-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240409556-A1 BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD YAP1, TEAD2, TEAD3 HTR6 4091/4885HRH3 3469/4885KDM4E 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.